经脐单孔腹腔镜根治性肾切除术研究（附12例病例报告）

Transumbilical laparoendoscopic single-site radical nepherectomy（a report of 12 cases）

摘要:

目的 评价应用经脐单孔腹腔镜手术（laparoendoscopic single-site surgery，LESS）行根治性肾切除术治疗肾脏肿瘤的安全性及可行性。方法 回顾性分析该院2011年6月-2012年11月经脐单孔腹腔镜肾癌根治术12例。研究患者一般情况、肿瘤大小、手术时间、术中估计出血量、术中术后并发症数、术后镇痛药物使用情况、术后视觉模拟疼痛评分（visual analong pain scale，VAPS）和术后住院天数等指标。结果 经脐单孔腹腔镜组2例在剑突下增加一5 mm辅助孔后完成，均未中转开放。手术疗效满意，美容效果好，术后平均随访（9.5±5.3）（3～15）个月，无复发及转移。结论 LESS根治性肾切除术治疗肾脏肿瘤安全可行，但需更多的研究进一步验证。

Abstract:

【Objective】 To verify the safety and feasibility of transumbilical laparoendoscopic single-site surgery (LESS) radical nephrectomy in the treatment of kidney tumors. 【Methods】 Prospective analysis of transumbilical laparoendoscopic single-site surgery (LESS) (12 cases) was conducted from April 2011 to November 2012. Patient condition, tumor characteristics, operating time, blood loss, complications, analgesic use, visual analong pain scale (VAPS) and days of hospital stay were analyzed. 【Results】 All 12 cases were successfully performed. 2 cases added a 5-mm trocar, and none convert to open surgery. The patients were followed up for (9.5±5.3) (3~15) months, no evidence of recurrence or metastasis was detected.【Conclusion】 LESS is safe and technically feasible for the treatment of renal tumor but need further clinical investigation.